popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator	spinal anesthesia with 2.5 ml of 0.5% bupivacaine 	The use of midazolam	12356	12501	he use of midazolam was more frequent in the spinal anesthesia group than in the PSNB group, but there was no statistical significance (Table 2).
popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator	spinal anesthesia with 2.5 ml of 0.5% bupivacaine 	unpleasant feelings during surgery and anxiety	12503	12661	According to the survey, unpleasant feelings during surgery and anxiety were higher in the spinal anesthesia group, but there was no statistical significance.
popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator	spinal anesthesia with 2.5 ml of 0.5% bupivacaine 	satisfied with the anesthesia procedure	13049	13334	In the satisfaction survey, 60% (12 cases) of the spinal anesthesia group and 85% (17 cases) of the PSNB group responded that they were satisfied with the anesthesia procedure (including those who responded 'average'), although the results were not statistically significant (Table 4).
popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator	spinal anesthesia with 2.5 ml of 0.5% bupivacaine 	The use of midazolam	12355	12501	The use of midazolam was more frequent in the spinal anesthesia group than in the PSNB group, but there was no statistical significance (Table 2).
popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator	spinal anesthesia with 2.5 ml of 0.5% bupivacaine 	Incisional pain	12850	13047	Incisional pain was not reported in the spinal anesthesia group but was reported by 15% (3 cases) of patients in the PSNB group; however, these figures were not statistically significant (Table 3).
popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator	spinal anesthesia with 2.5 ml of 0.5% bupivacaine 	The duration of the procedure, time from anesthesia induction until start of surgery, and surgery time	11720	11901	The duration of the procedure, time from anesthesia induction until start of surgery, and surgery time were shorter in the spinal anesthesia group than in the PSNB group (P < 0.01).
popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator	spinal anesthesia with 2.5 ml of 0.5% bupivacaine 	he anesthesia-related side effects	11902	12238	The anesthesia-related side effects in the spinal anesthesia group were hypotension, bradycardia, shivering, vomiting, postoperative headache, and urinary retension, occurring in 15%, 10%, 5%, 5%, 10%, and 20% of patients, respectively. There was no incidence of side effects in the PSNB group, but it was not statistically significant.
